Modernizing the Delaware Research and Development Tax Credit: Addressing the Geographic Barrier for Small and Medium Enterprises in the Remote Era

Author: Luisa Avila | Delaware R&D Tax Policy Consultant
Published: July 31, 2026 | Series: Swanson Reed State Tax Incentives

Answer Capsule: Why Does Delaware’s Geographic R&D Requirement Create a “Fiscal Imbalance” for Startups?

Under 30 Del. C. § 2070, Delaware enforces a strict “physicality” requirement, denying the state R&D tax credit for wages paid to remote engineers or researchers physically located outside state borders. Paradoxically, under the “convenience of the employer” rule (TIM 2021-2), Delaware taxes the personal income of those exact same remote workers. This creates a massive fiscal imbalance where the state captures revenue from remote labor but refuses to subsidize the innovation that labor produces. To prevent “Headquarter Leakage,” Delaware must legislatively align R&D eligibility with Personal Income Tax (PIT) sourcing, ensuring any wage subject to Delaware PIT qualifies for the fully refundable R&D credit.

Key Takeaways

The Double-Dipping Conflict: Delaware taxes the income of remote workers (via the convenience of the employer rule) but denies the hiring SMB the R&D tax credit for those same workers because the research is not “conducted in Delaware,” severely limiting startup liquidity.
Regional Disadvantage: Modern biotech and fintech innovation relies on distributed talent and specialized Mid-Atlantic labs. Rigidly restricting R&D claims to in-state coordinates forces Delaware startups into a massive competitive disadvantage compared to states like New York and Vermont that have adapted nexus rules.
Headquarter Leakage Risk: If Delaware’s primary innovation incentive remains inaccessible due to modern remote work arrangements, highly mobile “asset-light” startups will simply migrate their headquarters to more permissive jurisdictions, draining future corporate and payroll tax bases.
Proposed Solution 1 (PIT Alignment): Amend 30 Del. C. § 2070 to define Delaware QREs to include any wages subject to Delaware personal income tax withholding, instantly harmonizing the state’s tax capture with its incentive distributions.
Proposed Solution 2 (Regional Reciprocity): Implement a “Strategic Capability Exception” allowing Delaware SMBs to claim specialized contract research conducted within the Mid-Atlantic Innovation Corridor, capped at 50% of total QREs, provided IP ownership and management remain anchored in Delaware.

1. The Economic Imperative for R&D Tax Policy Alignment

The innovation landscape of Delaware stands at a critical juncture, defined by a historic strength in life sciences and a burgeoning fintech sector, yet constrained by a statutory framework that has struggled to keep pace with the decentralized nature of modern scientific and technological development. Since its inception, the Delaware Research and Development (R&D) tax credit has served as a pivotal mechanism for fostering industrial growth, yet its current geographic restrictions—mandating that research activities be conducted physically within the state’s borders to qualify for incentives—now act as a significant barrier for the very small to medium businesses (SMBs) it is intended to support. As Delaware seeks to maintain its status as a premier hub for global innovation, the legislature must consider the implications of the “physical presence” requirement in an age of remote work and specialized, fragmented laboratory ecosystems.

2. The Statutory Evolution of Research Incentives in Delaware

To understand the current policy friction, it is necessary to examine the historical trajectory of Delaware Title 30, Chapter 20, Subchapter VIII. The Delaware R&D tax credit was originally designed to provide a localized parallel to the federal incentives found in Internal Revenue Code (IRC) Section 41.¹ For decades, the credit operated under an aggregate statewide fiscal cap, which limited its utility for rapidly growing firms. However, a transformative legislative shift occurred with the passage of the Commitment to Innovation Act in 2017.² This legislation removed the $5 million aggregate statewide cap and, more importantly for the startup ecosystem, converted the credit into a fully refundable asset for qualified small businesses.²

This refundability means that if a taxpayer cannot utilize the entire amount of the approved credit against their corporate or personal income tax liability, the unused portion is paid directly as a cash refund.¹ For Delaware’s life sciences and technology sectors, where companies often incur massive research expenses years before reaching profitability, this provision provides essential liquidity. The statute currently defines a “small business” for these purposes as any taxpayer with average annual gross receipts not exceeding a specific statutory threshold, which is adjusted annually for inflation under 30 Del. C. § 515.¹ For the 2025/2026 period, this threshold has trended toward approximately $31 million, significantly broadening the pool of eligible SMBs.²

3. The Mechanics of the Current Credit Framework

The Delaware framework allows for two distinct calculation methods, and the taxpayer’s election is independent of their federal R&D credit choice.⁷ Method A, the regular incremental method, provides a credit equal to 10% of the excess of the taxpayer’s Delaware qualified research and development expenses over the Delaware base amount.¹ For SMBs, this rate is doubled to 20%.¹ Method B, based on the Alternative Simplified Credit (ASC), allows taxpayers to claim 50% of Delaware’s apportioned share of the federal research and development tax credit.¹ Again, for small businesses, this benefit is amplified to 100% of the apportioned share.¹

Table 1: Disparity Between Standard Corporate Rates and Enhanced SMB Incentives

Statutory Provision	Standard Corporate Rate	SMB Rate (Gross Receipts < $31M)
Regular Method (Excess QREs)	10%	20%
ASC Method (% of Apportioned Federal)	50%	100%
Refundability Status	Non-Refundable (Generally)	Fully Refundable
Aggregate Statewide Cap	$0.00 (Repealed 2017)	$0.00 (Repealed 2017)
Application Deadline	September 15th	September 15th

Source: ¹

4. The Policy Issue: The Geographic Border Barrier

Despite these robust incentives, the credit is functionally limited by its strict geographic nexus. Under 30 Del. C. § 2070, qualified research must physically take place within the geographical borders of Delaware.² This means that qualified research expenses (QREs) are apportioned based strictly on where the activities are performed, not where the company is headquartered or where the intellectual property is owned.²

For modern SMBs, this “physicality” requirement creates several operational hurdles. First, the pool of specialized talent—particularly in fields such as quantum computing, advanced bioinformatics, and specialized medicinal chemistry—is often distributed across the Mid-Atlantic region. A Delaware-based fintech startup may find its most qualified software architect resides in Maryland or Pennsylvania. Under current rules, the wages paid to that architect do not qualify for the Delaware R&D credit, even if their work is essential to the development of a business component housed in a Wilmington server.⁹

Second, the life sciences sector frequently requires “contract research” performed by third-party Contract Research Organizations (CROs). If a Delaware biotech firm utilizes a specialized lab in New Jersey for high-throughput screening or clinical sample analysis because no such facility exists in-state, those expenses are entirely excluded from the Delaware credit calculation.⁴ This places Delaware firms at a competitive disadvantage compared to peers in states with more flexible nexus requirements.

The Conflict with Remote Work Sourcing Rules

The policy issue is further complicated by a contradiction in how Delaware sources income versus how it grants tax credits. Under 30 Del. C. § 1124(b) and administrative guidance provided in TIM 2021-2, Delaware utilizes the “convenience of the employer” rule for personal income tax sourcing.⁹ This rule states that if an employee works from home in another state for their own convenience, their wages are still considered “attributable to employment in this State” and are taxed accordingly by Delaware.⁹

Consequently, Delaware currently taxes the income of remote workers on the basis that they are “employed in Delaware,” while simultaneously denying the employer the R&D tax credit for those same workers on the basis that the research is “not conducted in Delaware”.⁹ This creates a fiscal imbalance where the state captures the revenue from the labor but refuses to subsidize the innovation that labor produces. For an SMB, this can represent a loss of tens of thousands of dollars in annual liquidity, often representing the difference between hiring an additional researcher or deferring a project.

5. Comparative State Analysis: The Competitive Landscape

Delaware’s neighbors and competitors have adopted varying approaches to the geographic scope of their innovation incentives. While many states mirror the federal IRC § 41 definition, their application to out-of-state expenses varies significantly.

Table 2: Regional Comparative Analysis

State	Geographic Requirement for R&D Credit	SMB-Specific Enhancements
Delaware	Strictly within state borders	Double rate and 100% refundability
Alaska	Anywhere in U.S. (apportioned to AK)	18% of Federal credit allowed
Vermont	Strictly within state borders (linked to Fed)	Historically 27% of Federal; increasing to 75%
New York	Nexus-focused (Excelsior/Life Sciences)	Up to 20% for small Life Science firms
Maryland	Within state borders	Basic and Growth credit tiers for SMBs
California	Within state borders	Different “Gross Receipts” definition

Source: ¹¹

States like Alaska and Vermont provide a more integrated approach. Alaska allows the R&D credit for research conducted anywhere in the United States, provided the taxpayer has an Alaska tax presence, with the credit limited to a percentage of the federal credit apportioned to the state.¹³ Vermont recomputes a “hypothetical” federal credit using only state-sourced QREs but has recently moved to expand its credit cap and rate to compete for innovation-driven employers.¹⁵

New York, meanwhile, offers the Excelsior Research and Development Tax Credit and a specialized Life Sciences R&D Credit.¹⁴ The New York Life Sciences credit provides a refundable credit of up to $500,000 per year at a rate of 15-20% specifically for companies with fewer than 10 employees.¹⁴ These states recognize that for small firms, the ability to access cash is the primary driver of location decisions, even if some scientific activities occur across state lines.

6. Proposed Solution 1: Alignment with Personal Income Tax Sourcing

The most direct and administratively efficient solution for the Delaware legislature is to align the R&D tax credit’s geographic requirement with the state’s existing wage-sourcing standards.

Legislative Mechanism

The legislature should amend 30 Del. C. § 2070 to redefine “Delaware qualified research and development expenses” to include any wages that are subject to Delaware personal income tax withholding. Under this model, if a remote employee’s wages are sourced to Delaware under the “convenience of the employer” rule, those wages would automatically qualify as Delaware QREs for the R&D credit.⁹

This change would eliminate the current “double-dipping” scenario where the state taxes the labor but denies the incentive. By centering the nexus on the employment relationship rather than the physical GPS coordinates of the employee’s desk, Delaware would acknowledge the reality of the modern, decentralized technology workforce.

Impact on SMBs

For a Delaware-based SMB in the software or fintech space, this would immediately broaden the eligible credit base. A company headquartered in Wilmington with five developers—three of whom work remotely from Pennsylvania and New Jersey—currently loses 60% of its potential wage-based credit. Under this proposal, 100% of those developers’ wages would qualify, provided they are reported on Delaware W-2s and are subject to Delaware PIT. This would significantly increase the refundable cash payout for these firms, allowing them to reinvest in further talent acquisition or infrastructure within the state.

7. Proposed Solution 2: The Regional Laboratory Reciprocity Framework

To address the barrier created by specialized out-of-state laboratory services, Delaware should implement a “Strategic Capability Exception” or a “Regional Reciprocity” provision.

Legislative Mechanism

The state should allow SMBs to include contract research expenses paid to out-of-state entities in their Delaware QRE calculation, provided those entities are located within the “Mid-Atlantic Innovation Corridor” (defined as MD, PA, NJ, NY, and DC). This inclusion would be subject to several limiting factors to ensure that Delaware remains the primary beneficiary of the company’s growth:

Management Nexus: The research must be directed and managed by personnel physically located in Delaware.
IP Ownership: The intellectual property resulting from the research must be owned by the Delaware entity.
Apportionment Cap: Out-of-state contract research could be capped at a specific percentage (e.g., 50%) of the total Delaware QREs, ensuring that the majority of the research activity remains anchored to the state’s economy.

Strategic Rationale

This policy recognizes that Delaware’s life sciences industry, while robust, cannot be all things to all researchers. By allowing a small biotech firm to utilize a specialized genomic sequencing lab in Maryland without losing its Delaware tax benefits, the state encourages that firm to keep its high-value headquarters and management functions in Delaware.³ It prevents the “all-or-nothing” migration where a company relocates its entire operation to another state simply to capture a tax credit on a critical out-of-state research contract.

8. Implementation: Safeguarding Against Fraud and Wastage

Expanding the geographic scope of a refundable tax credit requires a rigorous oversight framework to prevent the systematic inflation of claims or the use of “shell” employees. Delaware can leverage federal standards and specialized administrative roles to maintain the integrity of the program.

Contemporaneous Documentation and Audit Triggers

The Delaware Division of Revenue should mandate “Contemporaneous Documentation” for all remote and out-of-state R&D claims, following the standards set by the IRS for federal audits.¹⁹ SMBs must maintain records created at or near the time research was performed, including:

Project descriptions outlining technical objectives and uncertainties.²¹
Detailed payroll records linking specific employee hours to R&D projects.²²
Third-party contracts that clearly state the Delaware entity bears the “economic risk” of the research.¹⁹

The Dual Professional Sign-Off Requirement

To mitigate the risk of aggressive vendors or “R&D mills” inflating claims, Delaware should implement a mandatory dual-professional sign-off for any credit claim exceeding a certain threshold (e.g., $100,000 in QREs). The claim would require certification from:

A Certified Public Accountant (CPA): To verify the financial accuracy and quantification of the expenses.²³
A Qualified Technical Professional: To verify that the activities meet the federal “Four-Part Test”—specifically that the work is technological in nature and involves a process of experimentation.⁵

Utilization of the Fraud Enforcement Advisor Model

Delaware should establish a state-level “Fraud Enforcement Advisor” (FEA) within the Division of Revenue, modeled after the IRS’s Office of Fraud Enforcement.²⁵ This advisor would utilize data analytics to flag anomalies, such as companies claiming 100% of their R&D for remote workers with no physical Delaware footprint. By focusing on “affirmative acts of fraud” and utilizing the Specialist Referral System (SRS), the state can protect the fiscal health of the program while providing a predictable environment for legitimate SMBs.²⁵

9. Cost Analysis and the Innovation Multiplier Effect

A common concern with expanding tax credits is the immediate impact on the state’s General Fund. However, a nuanced cost analysis reveals that the initial outlay for a modernized R&D credit is an investment that generates future revenue through high-quality job creation and corporate retention.

Projected Revenue Impact

According to the 2025 Delaware Tax Preference Report, the current R&D tax credit results in an estimated revenue loss of $25.7 million per year.²⁷ Expanding the geographic scope to include remote talent and regional labs for SMBs is estimated to increase this loss by approximately 12-18%, or roughly $3 million to $4.6 million annually.

The Long-Term Return on Investment (ROI)

The “Innovation Multiplier” suggests that these costs will be recouped over a 5-to-10-year horizon. Research by MIT indicates that areas introducing robust R&D tax credits experience a 20% rise in “high-quality” new-firm formation over a decade.²⁸ In Delaware, a single high-growth life sciences startup, such as Synnovation Therapeutics or WuXi STA, can generate hundreds of high-paying jobs (salaries often $100,000+).²⁹

The future benefits that pay for the program include:

PIT Capture: By sourcing remote workers to Delaware, the state captures personal income tax that would otherwise go to Maryland or Pennsylvania. A single $150,000 software engineer generates several thousand dollars in annual PIT, effectively offsetting the cost of their portion of the R&D credit.
Corporate Income Tax (CIT) Growth: As SMBs scale from research to commercialization, their transition to profitability generates substantial CIT. The 2017 Commitment to Innovation Act was predicated on the idea that keeping these firms in Delaware during their non-profitable years ensures the state reaps the tax rewards once they go to market.²
Spillover Benefits: R&D spending has been shown to have “spillover” effects that benefit other companies in the state, increasing overall productivity and industrial intensity.³¹ Delaware currently ranks 6th in the U.S. for industrial R&D intensity, a position that would be fortified by this policy change.³

Table 3: Cost-Benefit Projection Matrix

Fiscal Metric	Current Policy (FY 2025)	Proposed Modernized Policy (FY 2027 Proj.)
Annual State Outlay	$25.7 Million	$29.5 – $30.3 Million
High-Quality Startup Growth Rate	Baseline	+20% (10-year target)
Talent Retention (Remote)	Low (Geographic Exclusion)	High (Nexal Inclusion)
SMB Cash Liquidity Index	Moderate	High

Source: ⁴

10. The Strategic Importance of Policy Modernization

The risk of maintaining the status quo is not merely the loss of a tax credit; it is the loss of Delaware’s competitive edge in the regional and global innovation market. The “physicality” requirement of Section 2070 is increasingly out of step with how science and technology are developed.

The Danger of Innovation Stagnation

If Delaware continues to exclude remote and regional R&D expenses, it will inadvertently encourage its most promising SMBs to relocate. For a small firm, the tax credit is a significant portion of their operating budget. If that firm can move its headquarters 30 miles to a state with a more permissive credit structure, it will do so, taking its management team, its future profits, and its intellectual property with it.

The Consequence of Inaction: “Headquarter Leakage”

As noted in the 2025 Tax Preference Report, intangible assets (such as IP) are highly mobile and are often located in Delaware specifically because of tax incentives.²⁷ If the state’s primary innovation incentive becomes too difficult for SMBs to claim because of modern work arrangements, those intangible assets will follow the talent to other jurisdictions. This leads to a “hollowing out” of the state’s innovation ecosystem, where Delaware remains a place for manufacturing but loses the high-value “brain work” of research and design.

Furthermore, the recent federal changes under the One Big Beautiful Bill Act (OBBBA) have restored immediate expensing for domestic R&D, a move that provides a tailwind for innovation nationwide.³ By failing to update its own geographic rules, Delaware misses an opportunity to “stack” its state benefits with federal ones in a way that is seamless for the taxpayer. The administrative burden of tracking “Delaware-only” versus “Federal-all” expenses is a friction point that can be eliminated through legislative alignment.⁴

11. Conclusion and Recommendations

To ensure Delaware remains the most attractive jurisdiction for small and medium-sized innovative firms, the state legislature should pursue a two-pronged modernization of the R&D tax credit. First, the geographic physical presence requirement for wages must be replaced with a sourcing nexus that aligns with the “convenience of the employer” rule for personal income tax. This recognizes the value of the remote workforce while ensuring the state captures the associated tax revenue. Second, a regional reciprocity framework should be established for specialized contract research, allowing Delaware firms to utilize the best scientific resources in the Mid-Atlantic without forfeiting their local tax status.

These changes, while requiring a modest increase in the state’s annual tax preference outlay, represent a calculated investment in the “Innovation Economy.” By providing SMBs with the flexibility to hire the best talent and access the best labs, Delaware anchors these high-growth firms to its economy, securing its tax base for decades to come. With robust fraud prevention measures and a focus on long-term ROI, this policy shift will transform the Delaware R&D tax credit from a restrictive geographic mandate into a powerful, modern engine for economic growth.

Obras citadas

Delaware R&D Tax Credit | AndreTaxCo, PLLC, fecha de acceso: marzo 16, 2026, https://www.andretaxco.com/delaware-rdcredit
30 Delaware Code § 2070 (2025) – Amount of credit and applicable procedures., fecha de acceso: marzo 16, 2026, https://law.justia.com/codes/delaware/title-30/chapter-20/subchapter-viii/section-2070/
R&D Benefits for DE Innovators Restored | DPP – Delaware Prosperity Partnership, fecha de acceso: marzo 16, 2026, https://www.choosedelaware.com/in-the-news/rd-benefits-for-de-innovators-restored/
Delaware R&D Tax Credits – Strike Tax Advisory, fecha de acceso: marzo 16, 2026, https://www.striketax.com/state-rd-credits/delaware-r-d-tax-credits
Are R&D Tax Credits Available in Delaware? | See if You Qualify – KBKG, fecha de acceso: marzo 16, 2026, https://www.kbkg.com/research-tax-credit/delaware-rd-tax-credit
Income, Inheritance and Estate Taxes – Delaware Code Online, fecha de acceso: marzo 16, 2026, https://delcode.delaware.gov/title30/c020/sc08/index.html
BuS-rdc – State of Delaware, fecha de acceso: marzo 16, 2026, https://revenuefiles.delaware.gov/2025/BusinessTaxForms_Instructions/BUS-RDC_2025-01_PaperInteractive.pdf
FORM 2071AC 0007 – State of Delaware, fecha de acceso: marzo 16, 2026, https://revenuefiles.delaware.gov/docs/2071ACe.pdf
DELAWARE DIVISION OF REVENUE … – State of Delaware, fecha de acceso: marzo 16, 2026, https://revenuefiles.delaware.gov/2021/TIM%202021-2%20-%20treatment%20of%20remote%20work%20in%202020.pdf
State R&D Tax Credits for Biotech: The Hidden Opportunity Most Life Sciences Companies Miss – Boast, fecha de acceso: marzo 16, 2026, https://www.boast.ai/en-us/blog/r-and-d/state-rd-tax-credits-for-biotech-the-hidden-opportunity-most-life-sciences-companies-miss
State-level R&D tax credits vs. Federal R&D credits – Swanson Reed, fecha de acceso: marzo 16, 2026, https://www.swansonreed.com/research-tax-credit/federal/faqs/state-level-rd-tax-credits-vs-federal-rd-credits/
Appendix F: R&D tax incentives by state – JLARC, fecha de acceso: marzo 16, 2026, https://jlarc.virginia.gov/pdfs/oversight/ED_initiatives/SciTech%20Appendix%20F.pdf
Research & Development Tax Credits by State – Abdo, fecha de acceso: marzo 16, 2026, https://abdosolutions.com/research-development-tax-credits-by-state/
R&D Tax Credits in New York – GOAT Tax, fecha de acceso: marzo 16, 2026, https://www.goat.tax/state-details/r-d-tax-credits-new-york
Vermont R&D Tax Credits, fecha de acceso: marzo 16, 2026, https://www.striketax.com/state-rd-credits/vermont-r-d-tax-credits
Research & Development Tax Credit (Credit for Increasing Research Activities) – Vermont Legislature, fecha de acceso: marzo 16, 2026, https://legislature.vermont.gov/Documents/2018/WorkGroups/House%20Ways%20and%20Means/Budget/W~Sara%20Teachout~RandD%20Tax%20Credit%20~2-15-2017.pdf
Federal Tax Conformity Bill Advances with Expanded R&D Incentives for Vermont Businesses, fecha de acceso: marzo 16, 2026, https://www.vtchamber.com/vermont-tax-conformity-bill-2026-rd-credit/
New York Biotechnology and Life Sciences R&D Tax Credits: Key Opportunities and Deadlines – EisnerAmper, fecha de acceso: marzo 16, 2026, https://www.eisneramper.com/industries/life-sciences/biotechnology-life-science-tax-credit-key-opportunities-deadlines-0126/
What Are R&D Tax Credits and Why You Should Know About Them – Doc Wealth, fecha de acceso: marzo 16, 2026, https://www.docwealth.io/post/what-are-r-d-tax-credits-and-why-you-should-know-about-them
How Can I Prepare for an R&D Credit Audit? – Gusto, fecha de acceso: marzo 16, 2026, https://gusto.com/resources/articles/taxes/prepare-for-r&d-tax-credit-audit
Goal: Minimize Tax Exposure (CEO) – MGO CPA, fecha de acceso: marzo 16, 2026, https://www.mgocpa.com/goal/minimize-tax-exposure-ceo/
Construction Businesses Shouldn’t Overlook the R&D Credit – Thompson Greenspon, fecha de acceso: marzo 16, 2026, https://www.tgccpa.com/construction-businesses-shouldnt-overlook-the-rd-credit/
Common R&D tax credit scams to avoid, fecha de acceso: marzo 16, 2026, https://www.swansonreed.com/research-tax-credit/federal/faqs/common-rd-tax-credit-scams-to-avoid/
Qualified Research Expenditures | McGuire Sponsel Specialty Tax, fecha de acceso: marzo 16, 2026, https://mcguiresponsel.com/qualified-research-expenditures/
25.1.2 Recognizing and Developing Fraud | Internal Revenue Service, fecha de acceso: marzo 16, 2026, https://www.irs.gov/irm/part25/irm_25-001-002
Remote Authentication Fraud | FedPayments Improvement, fecha de acceso: marzo 16, 2026, https://fedpaymentsimprovement.org/strategic-initiatives/payments-security/remote-authentication-fraud/
CORPORATE INCOME TAX – State of Delaware, fecha de acceso: marzo 16, 2026, https://financefiles.delaware.gov/Reports/TaxPref/4-CIT-2025_KTR.pdf
State-level R&D tax credits spur growth of new businesses | MIT News, fecha de acceso: marzo 16, 2026, https://news.mit.edu/2020/state-rd-tax-credits-growth-new-businesses-0612
Synnovation Chooses to Expand in Delaware | DPP, fecha de acceso: marzo 16, 2026, https://www.choosedelaware.com/press-releases/synnovation-chooses-to-expand-in-delaware/
Partnership, Prosperity & Progress | Year in Review 2022, fecha de acceso: marzo 16, 2026, https://www.choosedelaware.com/wp-content/uploads/2023/05/Partnership-Prosperity-Progress-Year-in-Review-2022.pdf
RD142 (Published 2023) – Science and Technology Incentives: Economic Development Incentives Evaluation Series – June 13, 2022, fecha de acceso: marzo 16, 2026, https://rga.lis.virginia.gov/Published/2023/RD142

Notice & Disclaimer: The information is current as of July 31, 2026. This whitepaper is provided for discussion purposes only and should not be construed as legal or tax advice. It is strongly recommended that you seek professional legal or tax representation to understand how the Delaware R&D tax credit and any proposed policy changes would apply to specific business circumstances.